Abingworth

Activities: Finance

Trending Articles

  1. Solvent recycler SPR-200 boosts sustainability in pharma labs Recycling up to 90% of solvent in isocratic HPLC improves lab efficiency and sustainability
  2. IFF Pharma Solutions launches customer experience platform, AnswerCenter AnswerCenter is part of IFF's ongoing digitalisation initiative, allowing customers to easily access tailored pharmaceutical excipient solutions
  3. Nipro and Owen Mumford partner to distribute drug delivery device, UniSafe The medical device is a patient-centric method for the delivery of injectable medicines, and is designed to enhance compliance
  4. Neuraxpharm Group and Pharmathen partner to develop long-lasting psychiatric injectables The co-development deal aims to enhance patient compliance, with Pharmathen and Neuraxpharm holding rights to the product in North America and Europe, respectively
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    CDMO insights: development and manufacture of a highly potent OSD product In today’s pharmaceutical landscape, contract development and manufacturing organisations (CDMOs) are ubiquitous. Prior to the CDMO boom in the 1990s, however, this wasn’t...

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Abingworth announces strategic development financing agreement with Gilead Sciences

The financing agreement will provide up to $210 million in funding
Finance

Adaptate Biotherapeutics raises $18 m in Series A2 funding

The financing will also support the company’s expansion, including further recruitment and increased laboratory and office space
Recruitment

Abingworth appoints Brian Gallagher as Partner
Subscribe now